When cars were weird, they were clever. From Aztek coolers to hose-out floors, here are the so-called 'bad' ideas that ...
Top-line phase 2 results with Amgen's MariTide drug for obesity are finally in – but the highly anticipated doesn't seem to have lived up to investor expectations. MariTide (maridebart cafraglutide; ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback